Aspire Biopharma Holdings, Inc. ASBP
7.13 USD -0.41 (-5.44%)
Regular-session close
7.25 +0.12 +1.68%
After hours · Nov 20, 4:00 PM ET
7.10 Day range 8.12
4.65 52-week range 170.40
- YTD
- -95.50%
- 1 year
- -93.94%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 6.20K | 0 | 0 | 0 | 0 | |
| -116 | 0 | 0 | 0 | 0 | |
| -19.35M | -1.21M | -358.59K | -596.49K | -25.48K | |
| -24.48M | -1.31M | -359.07K | -597.12K | -25.48K | |
| -491.00 | -57.00 | -12.00 | 132.00 | — |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 1.00M | 3.63K | 11.17K | 38 | 0 | |
| 1.31M | 147.99K | 46.17K | 22.54K | 293.22K | |
| 7.69M | 1.69M | 534.03K | 151.33K | 293.70K | |
| 5.18M | 1.27M | 360.64K | 27.97K | 238.60K | |
| -6.38M | -1.54M | -487.86K | -128.79K | -475 |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -4.92M | -265.19K | 11.14K | -142.91K | -238.60K | |
| 5.92M | 257.64K | 0 | 4.85M | 238.60K | |
| 1.00M | -7.54K | 11.14K | -185.46K | 0 |
